bears on: What will be the impact of the NIH funding cuts on LGBTQ health…
A UCSF study was testing doxycycline to prevent sexually transmitted diseases.
No event time was recorded for this claim — the text gave nothing to anchor it to, and a guessed date would be worse than none.
Standing
lens: Evidence-weighted Structural
No belief has been computed for this claim under Evidence-weighted yet.
Questions this bears on
Bears on as evidence:
What will be the impact of the NIH funding cuts on LGBTQ health outcomes?
5 branches · 2 sources
What bears on it
Nothing supports or challenges this claim yet — untested, which is not the same as refuted.
Voices
- healthday.com restatement · zero weight
Voices are counted, never weighed. How many people say a thing is structure worth seeing; it is not, by itself, a reason to believe it.
What the documents actually said
The verbatim text each extraction read before resolving it into this canonical claim. Quoted, never republished.
- A UCSF study was testing doxycycline to prevent sexually transmitted diseases.
One study at the University of California, San Francisco (UCSF) was testing the antibiotic doxycycline to prevent sexually transmitted diseases like syphilis, gonorrhea and chlamydia, The Times reported.
Sources
Origin: extracted from $800M in LGBTQ Health Research Funding Nixed by Trump Administration · 2026-09-11 22:11